Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 98 entries
Sorted by: Best Match Show Resources per page
Correction to: Value of PET imaging for radiation therapy.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC.
PMID: 34617130
Strahlenther Onkol. 2021 Oct 06; doi: 10.1007/s00066-021-01851-9. Epub 2021 Oct 06.

No abstract available.

Cite
Lapa C, Nestle U, Albert NL, et al. Correction to: Value of PET imaging for radiation therapy. Strahlenther Onkol. 2021;doi: 10.1007/s00066-021-01851-9.
Lapa, C., Nestle, U., Albert, N. L., Baues, C., Beer, A., Buck, A., Budach, V., Bütof, R., Combs, S. E., Derlin, T., Eiber, M., Fendler, W. P., Furth, C., Gani, C., Gkika, E., Grosu, A. L., Henkenberens, C., Ilhan, H., Löck, S., Marnitz-Schulze, S., Miederer, M., Mix, M., Nicolay, N. H., Niyazi, M., Pöttgen, C., Rödel, C. M., Schatka, I., Schwarzenboeck, S. M., Todica, A. S., Weber, W., Wegen, S., Wiegel, T., Zamboglou, C., Zips, D., Zöphel, K., Zschaeck, S., Thorwarth, D., Troost, E. G. C. (2021). Correction to: Value of PET imaging for radiation therapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], . https://doi.org/10.1007/s00066-021-01851-9
Lapa, Constantin, et al. "Correction to: Value of PET imaging for radiation therapy." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. (2021). doi: https://doi.org/10.1007/s00066-021-01851-9
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC. Correction to: Value of PET imaging for radiation therapy. Strahlenther Onkol. 2021 Oct 06; doi: 10.1007/s00066-021-01851-9. Epub 2021 Oct 06. PMID: 34617130.
Copy Download .nbib Format: NLM
A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Gani C, Lo Russo M, Boeke S, Wegener D, Gatidis S, Butzer S, Boldt J, Mönnich D, Thorwarth D, Nikolaou K, Zips D, Nachbar M.
PMID: 34534612
Radiother Oncol. 2021 Nov;164:37-42. doi: 10.1016/j.radonc.2021.09.002. Epub 2021 Sep 14.

INTRODUCTION: Dose escalated radiotherapy has previously been investigated as a strategy to increase complete response rates in rectal cancer. However large safety margins are required using cone-beam computed tomography guided radiotherapy leading to high doses to organs at risk...

Cite
Gani C, Lo Russo M, Boeke S, et al. A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human. Radiother Oncol. 2021;164:37-42doi: 10.1016/j.radonc.2021.09.002.
Gani, C., Lo Russo, M., Boeke, S., Wegener, D., Gatidis, S., Butzer, S., Boldt, J., Mönnich, D., Thorwarth, D., Nikolaou, K., Zips, D., & Nachbar, M. (2021). A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 16437-42. https://doi.org/10.1016/j.radonc.2021.09.002
Gani, Cihan, et al. "A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 164 (2021): 37-42. doi: https://doi.org/10.1016/j.radonc.2021.09.002
Gani C, Lo Russo M, Boeke S, Wegener D, Gatidis S, Butzer S, Boldt J, Mönnich D, Thorwarth D, Nikolaou K, Zips D, Nachbar M. A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human. Radiother Oncol. 2021 Nov;164:37-42. doi: 10.1016/j.radonc.2021.09.002. Epub 2021 Sep 14. PMID: 34534612.
Copy Download .nbib Format: NLM
Differential transcription profiling of the phage LUZ19 infection process in different growth media.

RNA biology

Brandão A, Pires DP, Coppens L, Voet M, Lavigne R, Azeredo J.
PMID: 33448239
RNA Biol. 2021 Nov;18(11):1778-1790. doi: 10.1080/15476286.2020.1870844. Epub 2021 Jan 15.

RNA sequencing of phage-infected bacterial cultures offers a snapshot of transcriptional events occurring during the infection process, providing insights into the phage transcriptional organization as well as the bacterial response. To better mimic real environmental contexts, we performed RNA-seq...

Cite
Brandão A, Pires DP, Coppens L, et al. Differential transcription profiling of the phage LUZ19 infection process in different growth media. RNA Biol. 2021;18(11):1778-1790doi: 10.1080/15476286.2020.1870844.
Brandão, A., Pires, D. P., Coppens, L., Voet, M., Lavigne, R., & Azeredo, J. (2021). Differential transcription profiling of the phage LUZ19 infection process in different growth media. RNA biology, 18(11), 1778-1790. https://doi.org/10.1080/15476286.2020.1870844
Brandão, Ana, et al. "Differential transcription profiling of the phage LUZ19 infection process in different growth media." RNA biology vol. 18,11 (2021): 1778-1790. doi: https://doi.org/10.1080/15476286.2020.1870844
Brandão A, Pires DP, Coppens L, Voet M, Lavigne R, Azeredo J. Differential transcription profiling of the phage LUZ19 infection process in different growth media. RNA Biol. 2021 Nov;18(11):1778-1790. doi: 10.1080/15476286.2020.1870844. Epub 2021 Jan 15. PMID: 33448239; PMCID: PMC8583145.
Copy Download .nbib Format: NLM
Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7].

European journal of cancer (Oxford, England : 1990)

Benedikt Westphalen C, Bokemeyer C, Büttner R, Fröhling S, Gaidzik VI, Glimm H, Hacker UT, Heinemann V, Illert AL, Keilholz U, Kindler T, Kirschner M, Schilling B, Siveke JT, Schroeder T, Tischler V, Wagner S, Weichert W, Zips D, Loges S.
PMID: 34953660
Eur J Cancer. 2021 Dec 22; doi: 10.1016/j.ejca.2021.11.014. Epub 2021 Dec 22.

No abstract available.

Cite
Benedikt Westphalen C, Bokemeyer C, Büttner R, et al. Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]. Eur J Cancer. 2021;doi: 10.1016/j.ejca.2021.11.014.
Benedikt Westphalen, C., Bokemeyer, C., Büttner, R., Fröhling, S., Gaidzik, V. I., Glimm, H., Hacker, U. T., Heinemann, V., Illert, A. L., Keilholz, U., Kindler, T., Kirschner, M., Schilling, B., Siveke, J. T., Schroeder, T., Tischler, V., Wagner, S., Weichert, W., Zips, D., Loges, S. (2021). Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]. European journal of cancer (Oxford, England : 1990), . https://doi.org/10.1016/j.ejca.2021.11.014
Benedikt Westphalen, C, et al. "Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]." European journal of cancer (Oxford, England : 1990) vol. (2021). doi: https://doi.org/10.1016/j.ejca.2021.11.014
Benedikt Westphalen C, Bokemeyer C, Büttner R, Fröhling S, Gaidzik VI, Glimm H, Hacker UT, Heinemann V, Illert AL, Keilholz U, Kindler T, Kirschner M, Schilling B, Siveke JT, Schroeder T, Tischler V, Wagner S, Weichert W, Zips D, Loges S. Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]. Eur J Cancer. 2021 Dec 22; doi: 10.1016/j.ejca.2021.11.014. Epub 2021 Dec 22. PMID: 34953660.
Copy Download .nbib Format: NLM
Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy.

Physics and imaging in radiation oncology

Socarrás Fernández JA, Mönnich D, Leibfarth S, Welz S, Zwanenburg A, Leger S, Löck S, Pfannenberg C, La Fougère C, Reischl G, Baumann M, Zips D, Thorwarth D.
PMID: 33043157
Phys Imaging Radiat Oncol. 2020 Jul;15:52-59. doi: 10.1016/j.phro.2020.07.003.

BACKGROUND AND PURPOSE: Hypoxia Positron-Emission-Tomography (PET) as well as Computed Tomography (CT) radiomics have been shown to be prognostic for radiotherapy outcome. Here, we investigate the stratification potential of CT-radiomics in head and neck cancer (HNC) patients and test...

Cite
Socarrás Fernández JA, Mönnich D, Leibfarth S, et al. Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy. Phys Imaging Radiat Oncol. 2020;15:52-59doi: 10.1016/j.phro.2020.07.003.
Socarrás Fernández, J. A., Mönnich, D., Leibfarth, S., Welz, S., Zwanenburg, A., Leger, S., Löck, S., Pfannenberg, C., La Fougère, C., Reischl, G., Baumann, M., Zips, D., & Thorwarth, D. (2020). Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy. Physics and imaging in radiation oncology, 1552-59. https://doi.org/10.1016/j.phro.2020.07.003
Socarrás Fernández, Jairo A, et al. "Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy." Physics and imaging in radiation oncology vol. 15 (2020): 52-59. doi: https://doi.org/10.1016/j.phro.2020.07.003
Socarrás Fernández JA, Mönnich D, Leibfarth S, Welz S, Zwanenburg A, Leger S, Löck S, Pfannenberg C, La Fougère C, Reischl G, Baumann M, Zips D, Thorwarth D. Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy. Phys Imaging Radiat Oncol. 2020 Jul;15:52-59. doi: 10.1016/j.phro.2020.07.003. PMID: 33043157; PMCID: PMC7536307.
Copy Download .nbib Format: NLM
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.

International journal of cancer

Tawk B, Wirkner U, Schwager C, Rein K, Zaoui K, Federspil PA, Adeberg S, Linge A, Ganswindt U, Hess J, Unger K, Tinhofer I, Budach V, Lohaus F, Krause M, Guberina M, Stuschke M, Balermpas P, Rödel C, Grosu AL, Schäfer H, Zips D, Combs SE, Pigorsch S, Zitzelsberger H, Baumeister P, Kirchner T, Bewerunge-Hudler M, Weichert W, Hess J, Herpel E, Belka C, Baumann M, Debus J, Abdollahi A.
PMID: 34648658
Int J Cancer. 2021 Oct 14; doi: 10.1002/ijc.33842. Epub 2021 Oct 14.

Biomarkers with relevance for loco-regional therapy are needed in human papillomavirus negative aka HPV(-) head and neck squamous cell carcinoma (HNSCC). Based on the premise that DNA methylation pattern is highly conserved, we sought to develop a reliable and...

Cite
Tawk B, Wirkner U, Schwager C, et al. Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy. Int J Cancer. 2021;doi: 10.1002/ijc.33842.
Tawk, B., Wirkner, U., Schwager, C., Rein, K., Zaoui, K., Federspil, P. A., Adeberg, S., Linge, A., Ganswindt, U., Hess, J., Unger, K., Tinhofer, I., Budach, V., Lohaus, F., Krause, M., Guberina, M., Stuschke, M., Balermpas, P., Rödel, C., Grosu, A. L., Schäfer, H., Zips, D., Combs, S. E., Pigorsch, S., Zitzelsberger, H., Baumeister, P., Kirchner, T., Bewerunge-Hudler, M., Weichert, W., Hess, J., Herpel, E., Belka, C., Baumann, M., Debus, J., Abdollahi, A. (2021). Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy. International journal of cancer, . https://doi.org/10.1002/ijc.33842
Tawk, Bouchra, et al. "Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy." International journal of cancer vol. (2021). doi: https://doi.org/10.1002/ijc.33842
Tawk B, Wirkner U, Schwager C, Rein K, Zaoui K, Federspil PA, Adeberg S, Linge A, Ganswindt U, Hess J, Unger K, Tinhofer I, Budach V, Lohaus F, Krause M, Guberina M, Stuschke M, Balermpas P, Rödel C, Grosu AL, Schäfer H, Zips D, Combs SE, Pigorsch S, Zitzelsberger H, Baumeister P, Kirchner T, Bewerunge-Hudler M, Weichert W, Hess J, Herpel E, Belka C, Baumann M, Debus J, Abdollahi A. Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy. Int J Cancer. 2021 Oct 14; doi: 10.1002/ijc.33842. Epub 2021 Oct 14. PMID: 34648658.
Copy Download .nbib Format: NLM
Value of PET imaging for radiation therapy.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC.
PMID: 34259912
Strahlenther Onkol. 2021 Sep;197(9):1-23. doi: 10.1007/s00066-021-01812-2. Epub 2021 Jul 14.

This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring...

Cite
Lapa C, Nestle U, Albert NL, et al. Value of PET imaging for radiation therapy. Strahlenther Onkol. 2021;197(9):1-23doi: 10.1007/s00066-021-01812-2.
Lapa, C., Nestle, U., Albert, N. L., Baues, C., Beer, A., Buck, A., Budach, V., Bütof, R., Combs, S. E., Derlin, T., Eiber, M., Fendler, W. P., Furth, C., Gani, C., Gkika, E., Grosu, A. L., Henkenberens, C., Ilhan, H., Löck, S., Marnitz-Schulze, S., Miederer, M., Mix, M., Nicolay, N. H., Niyazi, M., Pöttgen, C., Rödel, C. M., Schatka, I., Schwarzenboeck, S. M., Todica, A. S., Weber, W., Wegen, S., Wiegel, T., Zamboglou, C., Zips, D., Zöphel, K., Zschaeck, S., Thorwarth, D., Troost, E. G. C. (2021). Value of PET imaging for radiation therapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 197(9), 1-23. https://doi.org/10.1007/s00066-021-01812-2
Lapa, Constantin, et al. "Value of PET imaging for radiation therapy." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. 197,9 (2021): 1-23. doi: https://doi.org/10.1007/s00066-021-01812-2
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC. Value of PET imaging for radiation therapy. Strahlenther Onkol. 2021 Sep;197(9):1-23. doi: 10.1007/s00066-021-01812-2. Epub 2021 Jul 14. PMID: 34259912.
Copy Download .nbib Format: NLM
Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer.

Cancer immunology, immunotherapy : CII

Hoffmann E, Paulsen F, Schaedle P, Zips D, Gani C, Rammensee HG, Gouttefangeas C, Eckert F.
PMID: 34269847
Cancer Immunol Immunother. 2021 Jul 16; doi: 10.1007/s00262-021-03002-6. Epub 2021 Jul 16.

PURPOSE: The influence of radiotherapy on patient immune cell subsets has been established by several groups. Following a previously published analysis of immune changes during and after curative radiotherapy for prostate cancer, this analysis focused on describing correlations of...

Cite
Hoffmann E, Paulsen F, Schaedle P, et al. Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer. Cancer Immunol Immunother. 2021;doi: 10.1007/s00262-021-03002-6.
Hoffmann, E., Paulsen, F., Schaedle, P., Zips, D., Gani, C., Rammensee, H. G., Gouttefangeas, C., & Eckert, F. (2021). Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer. Cancer immunology, immunotherapy : CII, . https://doi.org/10.1007/s00262-021-03002-6
Hoffmann, Elgin, et al. "Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer." Cancer immunology, immunotherapy : CII vol. (2021). doi: https://doi.org/10.1007/s00262-021-03002-6
Hoffmann E, Paulsen F, Schaedle P, Zips D, Gani C, Rammensee HG, Gouttefangeas C, Eckert F. Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer. Cancer Immunol Immunother. 2021 Jul 16; doi: 10.1007/s00262-021-03002-6. Epub 2021 Jul 16. PMID: 34269847.
Copy Download .nbib Format: NLM
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial.

European urology oncology

Hölscher T, Baumann M, Kotzerke J, Zöphel K, Paulsen F, Müller AC, Zips D, Koi L, Thomas C, Löck S, Krause M, Wirth M, Lohaus F.
PMID: 34785189
Eur Urol Oncol. 2021 Nov 13; doi: 10.1016/j.euo.2021.10.002. Epub 2021 Nov 13.

BACKGROUND: Local ablative radiotherapy (aRT) of oligometastatic prostate cancer (PCa) is very promising and has become a focus of current clinical research.OBJECTIVE: We hypothesize that aRT is safe and effective in gallium-68 prostate-specific membrane antigen targeted positron emission tomography...

Cite
Hölscher T, Baumann M, Kotzerke J, et al. Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial. Eur Urol Oncol. 2021;doi: 10.1016/j.euo.2021.10.002.
Hölscher, T., Baumann, M., Kotzerke, J., Zöphel, K., Paulsen, F., Müller, A. C., Zips, D., Koi, L., Thomas, C., Löck, S., Krause, M., Wirth, M., & Lohaus, F. (2021). Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial. European urology oncology, . https://doi.org/10.1016/j.euo.2021.10.002
Hölscher, Tobias, et al. "Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial." European urology oncology vol. (2021). doi: https://doi.org/10.1016/j.euo.2021.10.002
Hölscher T, Baumann M, Kotzerke J, Zöphel K, Paulsen F, Müller AC, Zips D, Koi L, Thomas C, Löck S, Krause M, Wirth M, Lohaus F. Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial. Eur Urol Oncol. 2021 Nov 13; doi: 10.1016/j.euo.2021.10.002. Epub 2021 Nov 13. PMID: 34785189.
Copy Download .nbib Format: NLM
Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study.

Biomolecules

Zirjacks L, Stransky N, Klumpp L, Prause L, Eckert F, Zips D, Schleicher S, Handgretinger R, Huber SM, Ganser K.
PMID: 34827559
Biomolecules. 2021 Oct 21;11(11). doi: 10.3390/biom11111561.

Mesenchymal glioblastoma stem cells (GSCs), a subpopulation in glioblastoma that are responsible for therapy resistance and tumor spreading in the brain, reportedly upregulate aldehyde dehydrogenase isoform-1A3 (ALDH1A3) which can be inhibited by disulfiram (DSF), an FDA-approved drug formerly prescribed...

Cite
Zirjacks L, Stransky N, Klumpp L, et al. Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study. Biomolecules. 2021;11(11)doi: 10.3390/biom11111561.
Zirjacks, L., Stransky, N., Klumpp, L., Prause, L., Eckert, F., Zips, D., Schleicher, S., Handgretinger, R., Huber, S. M., & Ganser, K. (2021). Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study. Biomolecules, 11(11), . https://doi.org/10.3390/biom11111561
Zirjacks, Lisa, et al. "Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study." Biomolecules vol. 11,11 (2021). doi: https://doi.org/10.3390/biom11111561
Zirjacks L, Stransky N, Klumpp L, Prause L, Eckert F, Zips D, Schleicher S, Handgretinger R, Huber SM, Ganser K. Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study. Biomolecules. 2021 Oct 21;11(11). doi: 10.3390/biom11111561. PMID: 34827559; PMCID: PMC8615869.
Copy Download .nbib Format: NLM
The need for the in(ter)dependent investigator.

Journal of the American College of Cardiology

Zipes DP.
PMID: 11345395
J Am Coll Cardiol. 2001 May;37(6):1751-2. doi: 10.1016/s0735-1097(01)01296-7.

No abstract available.

Cite
Zipes DP. The need for the in(ter)dependent investigator. J Am Coll Cardiol. 2001;37(6):1751-2doi: 10.1016/s0735-1097(01)01296-7.
Zipes, D. P. (2001). The need for the in(ter)dependent investigator. Journal of the American College of Cardiology, 37(6), 1751-2. https://doi.org/10.1016/s0735-1097(01)01296-7
Zipes, D P. "The need for the in(ter)dependent investigator." Journal of the American College of Cardiology vol. 37,6 (2001): 1751-2. doi: https://doi.org/10.1016/s0735-1097(01)01296-7
Zipes DP. The need for the in(ter)dependent investigator. J Am Coll Cardiol. 2001 May;37(6):1751-2. doi: 10.1016/s0735-1097(01)01296-7. PMID: 11345395.
Copy Download .nbib Format: NLM
Crassulacean Acid Metabolism and Crassulacean Acid Metabolism Modifications in Peperomia camptotricha.

Plant physiology

Sipes DL, Ting IP.
PMID: 16664028
Plant Physiol. 1985 Jan;77(1):59-63. doi: 10.1104/pp.77.1.59.

Peperomia camptotricha, a tropical epiphyte from Mexico, shows variable forms of Crassulacean acid metabolism (CAM). Young leaves exhibit CAM-cycling, while mature leaves show an intermediate type of metabolism, between CAM and CAM-cycling, having approximately the same amount of nighttime...

Cite
Sipes DL, Ting IP. Crassulacean Acid Metabolism and Crassulacean Acid Metabolism Modifications in Peperomia camptotricha. Plant Physiol. 1985;77(1):59-63doi: 10.1104/pp.77.1.59.
Sipes, D. L., & Ting, I. P. (1985). Crassulacean Acid Metabolism and Crassulacean Acid Metabolism Modifications in Peperomia camptotricha. Plant physiology, 77(1), 59-63. https://doi.org/10.1104/pp.77.1.59
Sipes, D L, and Ting, I P. "Crassulacean Acid Metabolism and Crassulacean Acid Metabolism Modifications in Peperomia camptotricha." Plant physiology vol. 77,1 (1985): 59-63. doi: https://doi.org/10.1104/pp.77.1.59
Sipes DL, Ting IP. Crassulacean Acid Metabolism and Crassulacean Acid Metabolism Modifications in Peperomia camptotricha. Plant Physiol. 1985 Jan;77(1):59-63. doi: 10.1104/pp.77.1.59. PMID: 16664028; PMCID: PMC1064456.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 98 entries